They orthogonally validated the expression of Trem2 in the heart after MI through immunohistochemistry, Western blotting, co-localization assays, flow cytometry, and quantitative RT–PCR (Figure 2 and Figure 3). This evidence concerns the gene TREM2 and myocardial infarction.